chartexchange

MeiraGTx Reports Third Quarter 2026 Financial and Operational Results

GlobeNewswire Inc. | Nov 12, 2026 8:00 AM EST

LONDON and NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced financial and operational results for the third quarter ended September 30, 2026, and provided a corporate update.

Read original article